Valuation Kyverna Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
7.930 ^USD	+9.08%		-1.00%	-15.64%

Jan. 31	Certain Restricted Stock Units of Kyverna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2026.	CI
Jan. 31	Certain Stock options of Kyverna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-FEB-2026.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027
Capitalization ¹	161.5	453	453	-
Change	-	180.58%	0%	-
Enterprise Value (EV) ¹	-124.5	266.3	295.9	261.2
Change	-	313.87%	11.1%	-11.72%
P/E ratio	-1.12x	-2.15x	-2.29x	-2.41x
PBR	0.61x	2.92x	4.07x	2.43x
PEG	0x	-0.2x	0.38x	0.48x
Capitalization / Revenue	-	-	-	28.2x
EV / Revenue	-	-	-	16.3x
EV / EBITDA	0.89x	-1.57x	-1.61x	-1.38x
EV / EBIT	0.87x	-1.53x	-1.52x	-1.22x
EV / FCF	1.07x	-1.89x	-1.7x	-1.61x
FCF Yield	93.5%	-52.9%	-58.8%	-62%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-3.33	-3.695	-3.469	-3.295
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	16.04
EBITDA ¹	-140.5	-170	-183.4	-189.6
EBIT ¹	-142.6	-174.4	-195	-214.7
Net income ¹	-127.5	-163.1	-184.9	-213.2
Net Debt ¹	-286	-186.7	-157.2	-191.9
Reference price ²	3.740	7.930	7.930	7.930
Nbr of stocks (in thousands)	43,172	57,130	57,130	-
Announcement Date	3/27/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
KYVERNA THERAPEUTICS, INC.	-2.15x	-	-1.57x	-	453M
LONZA GROUP AG	36.2x	5.26x	17.62x	0.95%	46.82B
BEONE MEDICINES AG	108.48x	6.96x	69.61x	-.--%	39.16B
CELLTRION, INC.	58.42x	11.94x	33.41x	0.33%	32.9B
IQVIA HOLDINGS INC.	26.51x	2.79x	11.94x	-.--%	31.8B
REVOLUTION MEDICINES, INC.	-17.45x	4983.42x	-16.28x	-.--%	18.85B
MEDPACE HOLDINGS, INC.	36.62x	5.92x	26.9x	-.--%	15.27B
Average	35.23x	836.05x	20.23x	0.21%	26.46B
Weighted average by Cap.	48.25x	514.15x	27.71x	0.3%